Future Outlook of the Rotavirus Vaccine Market: Growth, Trends, and Emerging Opportunities Explored
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the rotavirus vaccine market size evolved in recent years?
The market for the rotavirus vaccine has seen considerable expansion in the past few years. The market size is predicted to increase from $9.18 billion in 2024 to $10.14 billion in 2025, experiencing a compound annual growth rate (CAGR) of 10.5%. The surge during the historic period is a result of greater awareness about rotavirus, enhancement in healthcare facilities, government-regulated immunization initiatives, growing rates of rotavirus infections, and a rising birth rate.
What are the predictions for the rotavirus vaccine market size in the coming years?
The market size of the rotavirus vaccine is projected to experience fast-paced expansion in the coming years, reaching a size of $14.96 billion in 2029, with a compound annual growth rate (CAGR) of 10.2%. Factors contributing to this forecasted growth encompass increased birth rates, the broadening of vaccination campaigns, heightened emphasis on preventive health care, economic development and enhanced accessibility, as well as governmental policies and finances. Primary trends for the forecast period consist of progression in vaccine technology, advancements in oral administration methods, enhancements in vaccine formulas, combination vaccines, and the incorporation of digital health.
Get your rotavirus vaccine market report here!
https://www.thebusinessresearchcompany.com/report/rotavirus-vaccine-global-market-report
What key factors are fueling the growth of the rotavirus vaccine market?
The anticipated increase in birth rates globally is set to boost the rotavirus vaccine market’s growth. Birth rates are usually defined as the annual total of live births per 1,000 individuals in a population. Factors that affect birth rates include a robust economy and growth, supportive policies like parental leave, child benefits, and childcare subsidies. Rotavirus vaccines aid in decreasing the instances of severe rotavirus gastroenteritis in infants, thereby enhancing child health results and cutting hospital expenses linked to rotavirus infections. For example, a report released by the Centers for Disease Control and Prevention in January 2023 stated that the United States saw a rise in registered births by 1%, equaling a total of 3,664,292 births, in comparison to the prior year. As a result, the uptick in birth rates is anticipated to stimulate the expansion of the rotavirus vaccine market.
How is the global rotavirus vaccine market divided into key segments?
The rotavirus vaccine market covered in this report is segmented –
1) By Type: Rotarix, RotaTeq, Rotavac, Rotavin-M1, Lanzhou lamb, Other Types
2) By Application: Adult, Pediatric
3) By End Users: Hospitals, Clinics, Academic Research
Subsegments:
1) By Rotarix: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
2) By RotaTeq: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
3) By Rotavac: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
4) By Rotavin-M1: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
5) By Lanzhou Lamb: Dosing Schedule And Administration, Efficacy And Safety Profile, Target Demographics
6) By Other Types: Emerging Rotavirus Vaccines, Combination Vaccines, Region-Specific Vaccines
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20617&type=smp
Who are the key firms paving the way for growth in the rotavirus vaccine market?
Major companies operating in the rotavirus vaccine market are Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, GlaxoSmithKline plc, Daiichi Sankyo Company Limited, Serum Institute of India Private Limited, Sinovac Biotech Ltd., SK Chemicals Co Ltd., Bharat Biotech International Limited, Walvax Biotechnology Co. Ltd., Indian Immunologicals Limited, PT Bio Farma, KFF Inc., Panacea Biotec Limited, Sanyou Biopharmaceuticals Co. Ltd., Inovio Pharmaceuticals Inc., Hilleman Laboratories Private Limited, China National Biotec Group Corporation, Vabiotech, Lanzhou Institute of Biological Products Co. Ltd., Nuvonis Pharmaceuticals Inc., Chengdu Institute of Biological Products Co. Ltd
Which trends are expected to transform the rotavirus vaccine market?
Leading businesses in the rotavirus vaccine market are increasingly using oral-dosing applicators to better administer vaccines and promote patient compliance. These applicators are medical tools made to deliver liquid medicines or vaccines directly into the mouth, providing precise dosage and making it easier to use, particularly for babies and young children. For example, in November 2022, GSK plc, a pharmaceutical and biotechnology organization based in the UK, obtained approval from the U.S. Food and Drug Administration (FDA) for a new oral-dosing applicator-only formula of ROTARIX (Rotavirus Vaccine, Live, Oral). This fluid formula protects against rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9) in infants. This new introduction simplifies the vaccine preparation process for healthcare providers by removing the requirement for dose reconstitution at the time of use.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20617
What regions are contributing significantly to the growth of the rotavirus vaccine market?
North America was the largest region in the rotavirus vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rotavirus vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Meningococcal Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/meningococcal-vaccines-global-market-report
Swine Vaccines Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/swine-vaccines-global-market-report
Typhoid Vi Polysaccharide Vaccine Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
